Table 3.
Group effect p-value | Time effect p-value | Interaction | |
---|---|---|---|
Lipid profile | |||
Total cholesterol | <0.001 | 0.918 | F (4, 126) = 0.449, p = 0.773, partial η2 = 0.014 |
HDL-c | <0.001 | <0.001 | F (4, 126) = 0.429, p = 0.788, partial η2 = 0.013 |
LDL-c | <0.001 | 0.057 | F (4, 126) = 2.365, p = 0.056, partial η2 = 0.070 |
Triglycerides | 0.406 | <0.001 | F (3.521, 126) = 2.267, p = 0.075, partial η2 = 0.067 |
Apolipoprotein A | <0.001 | 1.000 | F (3.976, 124) = 0.707, p = 0.588, partial η2 = 0.022 |
Apolipoprotein B | <0.001 | 0.675 | F (3.805, 124) = 1.183, p = 0.322, partial η2 = 0.037 |
Inflammation | |||
Abs. leukocyte count | 0.131 | <0.001 | F (3.626, 124) = 4.280, p = .004, partial η2 = 0.121 |
Abs. neutrophile count | 0.063 | <0.001 | F (2.927, 124) = 5.892, p = 0.001, partial η2 = 0.160 |
Abs. lymphocyte count | 0.907 | <0.001 | F (4, 124) = 0.737, p = 0.568, partial η2 = 0.023 |
Abs. granulocyte count | 0.090 | 0.003 | F (3.850, 122) = 0.331, p = 0.850, partial η2 = 0.011 |
NLR | 0.674 | <0.001 | F (3.11, 124) = 0.290, p = 0.839, partial η2 = 0.009 |
Platelet activity | |||
Abs. Thrombocyte count | 0.525 | <0.001 | F (4, 124) = 1.303, p = 0.273, partial η2 = 0.040 |
MPV | 0.896 | 0.342 | F (4, 122) = 1.023, p = 0.398, partial η2 = 0.032 |
PDW | 0.634 | 0.207 | F (4, 124) = 1.022, p = 0.399, partial η2 = 0.032. |
Reticulated thrombocytes | 0.832 | 0.163 | F (4, 122) = 1.190, p = 0.319, partial η2 = 0.038 |
ADPtest | 0.021 | 0.003 | F (4, 126) = 0.751, p = 0.555, partial η2 = 0.023 |
ASPItest | <0.001 | 0.006 | F (4, 126) = 2.149, p = 0.079, partial η2 = 0.064 |
TRAPtest | 0.037 | 0.001 | F (3.641, 122) = 0.412, p = 0.782, partial η2 = 0.013 |
Abs.-absolute, ADPtest-adenosine diphosphate test performed using Multiplate test, ASPItest-arachidonic acid test performed using multiplate test, HDL-c- high-density lipoprotein cholesterol, LDL-c- low-density lipoprotein cholesterol, MPV- mean platelet volume, NLR-neutrophile-lymphocyte ratio, PDW- platelet distribution width, TRAPtest-thrombin receptor-activated peptide performed using multiplate test.